Records containing: Lymphoma, B-Cell
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-18Phase 1A/1B Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
-
CLINICAL_TRIALS study record update · 2025-09-08A Phase 1/2 Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ARQ 531 in Selected Subjects With Relapsed or Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-09-03Randomized Phase II Study of Two Associations of Rituximab and Chemotherapy, With a PET -Driven Strategy, in Patients From 18 to 59 With DLBCL CD20+ Lymphoma and 2 or 3 Adverse Prognostic Factors of the Age-adjusted IPI
-
CLINICAL_TRIALS study record update · 2025-09-02Early Assessment of Cardiac Function After Treatment With CAR-T Cells
-
CLINICAL_TRIALS study record update · 2025-07-31Supervised Machine Learning for the Prediction of Primary Refractory Status in Patients With Diffuse Large Cell B Lymphoma in a Monocentric Cohort at the Grand Hôpital de Charleroi
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-28A Cancer Research UK Phase I/II Trial of ALETA-001 in Participants Who Have Received an Anti-CD19 CAR T-Cell Therapy for the Treatment of B-cell Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-02Retreatment With CTL019/CTL119 in Patients With Late Relapse of B-Cell Lymphomas
-
CLINICAL_TRIALS study record update · 2025-06-08Phase II Study of Pembrolizumab In Combination With R-CHOP for Patients With Untreated, High-Risk, Non-Germinal Center-Derived DLBCL
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase I Trial Evaluating the Safety of Consolidative Infusions of CD19-Specific Chimeric Antigen Receptor (CAR) T Cells Following T-cell Depleted Allogeneic Transplantation for High Risk B-cell Malignancies
-
CLINICAL_TRIALS study record update · 2025-05-06PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL Post Chimeric Antigen Receptor T-cEll Therapy fAilUre (PLATEAU Study)
-
CLINICAL_TRIALS study record update · 2025-05-02Defining the Role of ctDNA Monitoring in a Risk Stratified Clinical Trial for Posttransplant Lymphoproliferative Disorder (PTLD)
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase 1 Clinical Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (KEYNOTE-A33)
-
CLINICAL_TRIALS study record update · 2025-03-10Safety and Feasibility Study of CD19 Chimeric Antigen Receptor (CAR) T Cells in Children with Relapsed or Refractory CD19 Positive Acute Lymphoblastic Leukemia or Lymphoma
-
CLINICAL_TRIALS study record update · 2025-02-27Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor Gene Modified T Cells Targeting CD30 in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2025-02-21Open-Label, Phase 1 Study of CD19 t-haNK In Subjects With Diffuse Large B-Cell Lymphoma Who Have Received 2 Or More Lines of Therapy And Are Ineligible For Transplant
-
CLINICAL_TRIALS study record update · 2025-02-18A Single-arm, Open-label Clinical Study to Assess the Safety and Efficacy of the C752 CAR-T Cells for Patients With CD19+ Refractory/Relapsed B Cell Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2025-01-22An Exploratory Clinical Study of Keynatinib in Relapsed/Refractory B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2025-01-14A Phase 2, Multicenter, Open Label Dose-ranging Study of Sepantronium Bromide in Patients With Relapsed/Refractory c-Myc Rearranged High-grade B-cell Lymphoma (HGBCL)
-
CLINICAL_TRIALS study record update · 2024-12-12A Phase I Clinical Trial with CAR-37 T Cells for the Treatment of Patients with Relapsed or Refractory CD37+ Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-12-06A Phase I Study of Tagraxofusp With or Without Chemotherapy in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2024-10-15Prospective Clinical Study of Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2024-08-27A Real-World Study on Extranodal Lymphoma
-
CLINICAL_TRIALS study record update · 2024-08-09Contribution of Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome
-
CLINICAL_TRIALS study record update · 2024-07-16A Phase 2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)
-
CLINICAL_TRIALS study record update · 2024-05-24Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy